Fig. 1From: Viral transmission risk factors in an Egyptian population with high hepatitis C prevalenceComparison between the number and percent of subjects who received parenteral antischistosomal therapy (PAT) and the number and percent of those who were HCV positive (HCV Pos) for either HCV anti-bodies and/or RNA in each of the age groupBack to article page